Loading...

Purified anti-human CD4 Antibody

Pricing & Availability
Clone
RPA-T4 (See other available formats)
Regulatory Status
RUO
Workshop
IV T114
Other Names
T4
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
RPA-T4_Purified_060507
Human peripheral blood lymphocytes stained with purified RPA-T4, followed by anti-mouse IgGs FITC
  • RPA-T4_Purified_060507
    Human peripheral blood lymphocytes stained with purified RPA-T4, followed by anti-mouse IgGs FITC
Compare all formats
Cat # Size Price Quantity Check Availability Save
300501 25 µg 20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
300502 100 µg 32€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4, also known as T4, is a 55 kD single-chain type I transmembrane glycoprotein expressed on most thymocytes, a subset of T cells, and monocytes/macrophages. CD4, a member of the Ig superfamily, recognizes antigens associated with MHC class II molecules, and participates in cell-cell interactions, thymic differentiation, and signal transduction. CD4 acts as a primary receptor for HIV, binding to HIV gp120. CD4 has also been shown to interact with IL-16.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF® - Verified
Activ, Block, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The RPA-T4 antibody binds to the D1 domain of CD4 (CDR1 and CDR3 epitopes) and can block HIV gp120 binding and inhibit syncytia formation. Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections3,4,5, blocking of T cell activation1,2, and spatial biology (IBEX)10,11.  This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 300569 - 300574).

Application References
  1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York. (Activ)
  2. Moir S, et al. 1999. J. Virol. 73:7972. (Activ)
  3. Deng MC, et al. 1995. Circulation 91:1647. (IHC)
  4. Friedman T, et al. 1999. J. Immunol. 162:5256. (IHC)
  5. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
  6. Lan RY, et al. 2006. Hepatology 43:729.
  7. Zenaro E, et al. 2009. J. Leukoc. Biol. 86:1393. (FC) PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu J, et al. 2018. Cell Physiol Biochem. 45:1034. PubMed
  2. Fu J et al. 2019. Cell stem cell. 24(2):227-239 . PubMed
  3. Shahine A, et al. 2019. Nat Commun. 10:56. PubMed
  4. Meckiff BJ, et al. 2019. J Immunol. 203:1276. PubMed
  5. Ivan Jelcic et al. 2018. Cell. 175(1):85-100 . PubMed
  6. Taft J, et al. 2021. Cell. 184(17):4447-4463.e20. PubMed
  7. Alroqi F, et al. 2017. J Clin Immunol. . 10.1007/s10875-017-0451-1. PubMed
  8. Willing A, et al. 2018. J Immunol. 200:974. PubMed
  9. Campbell GR, et al. 2021. Theranostics. 11:9009. PubMed
  10. Chakhtoura M, et al. 2021. PLoS Pathog. 17:e1009732. PubMed
  11. Mo Y, et al. 2021. STAR Protocols. 2(2):100453. PubMed
  12. Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
  13. Kessel C, et al. 2017. Arthritis Rheumatol. 69:1480. PubMed
  14. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  15. Liu X, et al. 2022. STAR Protoc. 3:101310. PubMed
  16. Yang R, et al. 2020. Cell. 183(7):1826-1847.e31. PubMed
  17. Martin JC, et al. 2020. Cell. 178(6):1493-1508.e20.. PubMed
  18. Li H, et al. 2020. Front Immunol. 11:1777. PubMed
  19. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  20. O'Boyle KC, et al. 2020. Methods Mol Biol. 2111:1. PubMed
  21. Cosgrove PR, et al. 2021. Pediatr Res. . PubMed
  22. Bruno TC, et al. 2017. Cancer Immunol Res. 0.831944444. PubMed
  23. Kinosada H, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006120. PubMed
  24. Peng T, et al. 2021. Front Immunol. 12:735643. PubMed
  25. Jeyanathan M, et al. 2022. JCI Insight. 7:. PubMed
  26. Zhao J, et al. 2017. Sci Immunol. 2:eaan5400. PubMed
  27. Jakob M, et al. 2020. Cells. 10:. PubMed
  28. Gee MH, et al. 2018. Cell. 172:549. PubMed
  29. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  30. Henrick BM, et al. 2021. Cell. . PubMed
  31. Roussel M, et al. 2021. Cell Reports Medicine. 2(6):100291. PubMed
  32. Levin SD, et al. 2020. Front Immunol. 10:3086. PubMed
  33. Schwabenland M, et al. 2021. Immunity. . PubMed
  34. Bengsch B et al. 2018. Immunity. 48(5):1029-1045 . PubMed
  35. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  36. Senosain MF, et al. 2021. Sci Rep. 11:14424. PubMed
  37. Ford ES, et al. 2021. J Clin Invest. 131:. PubMed
  38. Anna F, et al. 2021. J Immunother Cancer. 9:. PubMed
  39. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  40. Lavaert M, et al. 2020. Frontiers in Immunology. 1.610416667. PubMed
  41. Sutherland APR, et al. 2019. Sci Rep. 9:15302. PubMed
  42. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  43. Ainai A, et al. 2020. Microbiol Immunol. 64:313. PubMed
  44. Lavin Y et al. 2017. Cell. 169(4):750-765 . PubMed
  45. Olety B, et al. 2021. Sci Adv. 7:eabj7398. PubMed
  46. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
RRID
AB_314069 (BioLegend Cat. No. 300501)
AB_314070 (BioLegend Cat. No. 300502)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, 55 kD
Distribution

T cell subset, majority of thymocytes, monocytes/macrophages

Function
MHC class II co-receptor, lymphocyte adhesion, thymic differentiation, HIV receptor
Ligand/Receptor
MHC class II molecules, HIV gp120, IL-16
Cell Type
Dendritic cells, Macrophages, Monocytes, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Center D, et al. 1996. Immunol. Today 17:476.
2. Gaubin M, et al. 1996. Eur. J. Clin. Chem. Clin. Biochem. 34:723.

Gene ID
920 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-human CD4 RPA-T4 FC
Biotin anti-human CD4 RPA-T4 FC
FITC anti-human CD4 RPA-T4 FC,SB
PE anti-human CD4 RPA-T4 FC
PE/Cyanine5 anti-human CD4 RPA-T4 FC
PE/Cyanine7 anti-human CD4 RPA-T4 FC
Purified anti-human CD4 RPA-T4 FC,CyTOF®,Activ,Block,IHC
APC/Cyanine7 anti-human CD4 RPA-T4 FC
Alexa Fluor® 488 anti-human CD4 RPA-T4 FC,ICC
Alexa Fluor® 647 anti-human CD4 RPA-T4 FC,SB
Pacific Blue™ anti-human CD4 RPA-T4 FC
Brilliant Violet 421™ anti-human CD4 RPA-T4 FC,ICC
Alexa Fluor® 700 anti-human CD4 RPA-T4 FC,SB
PerCP anti-human CD4 RPA-T4 FC
PerCP/Cyanine5.5 anti-human CD4 RPA-T4 FC
Brilliant Violet 570™ anti-human CD4 RPA-T4 FC
Brilliant Violet 650™ anti-human CD4 RPA-T4 FC
Purified anti-human CD4 (Maxpar® Ready) RPA-T4 FC,CyTOF®
Alexa Fluor® 594 anti-human CD4 RPA-T4 FC,ICC
Brilliant Violet 510™ anti-human CD4 RPA-T4 FC
PE/Dazzle™ 594 anti-human CD4 RPA-T4 FC
Brilliant Violet 785™ anti-human CD4 RPA-T4 FC
Brilliant Violet 605™ anti-human CD4 RPA-T4 FC
Brilliant Violet 711™ anti-human CD4 RPA-T4 FC
APC/Fire™ 750 anti-human CD4 RPA-T4 FC
CD4 Fluorophore Sampler Kit RPA-T4 FC
CD4 Fluorophore Sampler Kit with Veri-Cells™ PBMC RPA-T4 FC
TotalSeq™-A0072 anti-human CD4 RPA-T4 PG
TotalSeq™-B0072 anti-human CD4 RPA-T4 PG
TotalSeq™-C0072 anti-human CD4 RPA-T4 PG
Ultra-LEAF™ Purified anti-human CD4 RPA-T4 FC,CyTOF®,Activ,Block,IHC
TotalSeq™-D0072 anti-human CD4 RPA-T4 PG
Go To Top Version: 5    Revision Date: 08-23-2022

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-human CD4

  • Biotin anti-human CD4

  • FITC anti-human CD4

  • PE anti-human CD4

  • PE/Cyanine5 anti-human CD4

  • PE/Cyanine7 anti-human CD4

  • Purified anti-human CD4

  • APC/Cyanine7 anti-human CD4

  • Alexa Fluor® 488 anti-human CD4

  • Alexa Fluor® 647 anti-human CD4

  • Pacific Blue™ anti-human CD4

  • Brilliant Violet 421™ anti-human CD4

  • Alexa Fluor® 700 anti-human CD4

  • PerCP anti-human CD4

  • PerCP/Cyanine5.5 anti-human CD4

  • Brilliant Violet 570™ anti-human CD4

  • Brilliant Violet 650™ anti-human CD4

  • Purified anti-human CD4 (Maxpar® Ready)

  • Alexa Fluor® 594 anti-human CD4

  • Brilliant Violet 510™ anti-human CD4

  • PE/Dazzle™ 594 anti-human CD4

  • Brilliant Violet 785™ anti-human CD4

  • Brilliant Violet 605™ anti-human CD4

  • Brilliant Violet 711™ anti-human CD4

  • APC/Fire™ 750 anti-human CD4

  • CD4 Fluorophore Sampler Kit

  • CD4 Fluorophore Sampler Kit with Veri-Cells™ PBMC

  • TotalSeq™-A0072 anti-human CD4

  • TotalSeq™-B0072 anti-human CD4

  • TotalSeq™-C0072 anti-human CD4

  • Ultra-LEAF™ Purified anti-human CD4

  • TotalSeq™-D0072 anti-human CD4

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account